TL;DR — No compound replicates multi-hallmark signaling from consistent movement. Non-negotiables: 150+ min/week Zone 2, 2× resistance, optional weekly VO2max interval. Track resting HR, HRV, and hs-CRP — exercise is the signal; supplements are adjuvants.
Why this protocol comes first
Exercise is the highest-impact lifestyle intervention for longevity in the TNiC evidence hierarchy. It activates AMPK, PGC-1α, telomere maintenance pathways, senescence clearance support, and myokine reprogramming — simultaneously.
Meta-analyses link regular aerobic training with longer leukocyte telomeresProtective caps at the ends of chromosomes that shorten each time a cell divides, acting as a cellular lifespan counter. Full glossary →, lower hs-CRP, and reduced all-cause mortality. Effect sizes exceed most supplement interventions at comparable cost.
Hallmarks primarily affected: Mitochondrial dysfunction · Cellular senescence · Telomere attrition · Disabled macroautophagy · Chronic inflammation · Stem cell exhaustion
Meta-analyses associate regular aerobic training with longer leukocyte telomeres, lower hs-CRP, and reduced all-cause mortality. VO2max is among the strongest all-cause mortality predictors measurable in a lab or estimated via wearable.
The protocol — what to actually do
| Behavior | Target | Frequency | Evidence |
|---|---|---|---|
| Zone 2 cardio | 150–240 min/week | 3–4×/week | Tier A |
| Resistance training | Compound lifts, 6–12 reps | 2–3×/week | Tier A |
| VO2max intervals | 4×4 min @ 85–95% max HR | 1×/week | Tier A |
| Mobility / recovery | Dynamic warm-up + stretch | Daily 10–15 min | Tier B |
← Swipe for more columns →
Weekly schedule template
| Day | Session | Duration | Intensity | Target |
|---|---|---|---|---|
| Mon | Zone 2 | 45–60 min | HR 60–70% max | Mito base |
| Tue | Resistance | 30–45 min | 6–12 reps compound | Muscle + glucose |
| Wed | Zone 2 | 45 min | Conversational pace | Mito base |
| Thu | Resistance | 30–45 min | Progressive overload | Stem cell stimulus |
| Fri | Zone 2 | 45 min | HR 60–70% max | Mito base |
| Sat | VO2max intervals | 20–30 min | 4×4 min hard | Cardiorespiratory ceiling |
| Sun | Mobility / walk | 30 min | Low | Recovery |
← Swipe for more columns →
Minimum effective dose (WHO): 150 min moderate aerobic + 2 resistance sessions per week.
Week-one implementation
Day 1–3: Establish Zone 2 HR zone (220-age × 0.6–0.7, or wearable lactate proxy). One 30-min session only.
Day 4–7: Add second Zone 2 session. Log resting HR baseline.
Week 2+: Add resistance 2×/week. VO2max intervals only after 4 weeks Zone 2 base.
Environment hacks: Treadmill incline, stationary bike, rucking, or brisk hills — Zone 2 is pace, not equipment.
Which protocol variant fits you?
Currently sedentary (<60 min moderate activity/week)?
Start 3×30 min brisk walks week 1–4 → progress to Zone 2 — no VO2max until base built
node | HRV below baseline 3+ days or illness recovering?
Deload 50% volume 1–2 weeks — do not add stack compounds to compensate
Full pyramid: Zone 2 base + resistance + weekly VO2max
Chest pain, syncope, or known CAD without cardiologist clearance — stress test before intervals
Educational decision aid — a way to organize the evidence, not a prescription. Doses and timing shown are those used in studies; confirm anything you act on with a clinician or pharmacist.
How this connects to your stack
Exercise is the signal; supplements are adjuvants — never substitutes.
| If you're also running… | Interaction | Recommendation |
|---|---|---|
| NMN | NAD+ supports PGC-1α signaling | AM NMN; exercise provides biogenesis trigger |
| GlyNAC | ↓ exercise-induced oxidative recovery time | AM dose; not a pre-workout antioxidant |
| NAD+ Mito Stack | Ca-AKG supports TCA under load | Add stack after 4 weeks training consistency |
| Stress protocol | Low HRV = deload signal | Never train through HRV collapse |
Monitoring
| Signal | Tool | Frequency | Target |
|---|---|---|---|
| Zone 2 minutes | Log / wearable | Weekly | ≥150 min |
| Resistance sessions | Log | Weekly | ≥2 |
| Resting HR | Wearable | Daily avg | ↓ 2–5 bpm over 3 mo |
| HRV (rMSSD) | Wearable | 7-day avg | ↑ trend |
| hs-CRP | Lab | Baseline, 12 wk | <1.0 mg/L |
| VO2max | Test or estimate | Baseline, 6 mo | ↑ or age-stable |
← Swipe for more columns →
Zone 2 (min/wk)
<90
RHR (bpm)
Baseline
hs-CRP (mg/L)
>1.0
Resistance (sessions/wk)
<2
Zone 2 (min/wk)
≥150
RHR (bpm)
↓ 2–5
hs-CRP (mg/L)
<1.0
Resistance (sessions/wk)
≥2
Correlate lifestyle with labs
Log hs-CRP at baseline and week 12 — exercise lowers CRP independent of weight loss in trials.
Open Labs hubRed flags
When lifestyle isn't enough — or isn't safe
- Chest pain, dyspnea, or syncope during exertion — stop, cardiac evaluation
- HRV collapsed 5+ days + poor sleep — overtraining; deload before injury
- Joint pain >72h post-session — form, volume, or referral to sports medicine
Personal results template
My exercise log
| Date | Week | Zone 2 (min) | Resistance (sessions) | VO2max (Y/N) | RHR | HRV trend | Energy (1–10) | Compliance % | Notes |
|---|---|---|---|---|---|---|---|---|---|
| YYYY-MM-DD | 0 | — | — | — | — | — | — | — | Baseline |
| YYYY-MM-DD | 4 | — | — | — | — | — | — | — | Base built |
| YYYY-MM-DD | 12 | — | — | — | — | — | — | — | Primary checkpoint |
← Swipe for more columns →
Response criteria: - Meaningful: ≥150 min Zone 2 + RHR ↓2+ bpm + energy ≥7/10 - Plateau: Add VO2max interval or increase resistance load — single variable - Adverse: Persistent fatigue, illness frequency ↑ → deload 2 weeks
Model protocol impact
Simulate exercise pillar against mitochondrial and inflammation hallmark scores — often the highest single-lever gain in Protocol Engine.
Open Protocol Engine